Baxter International scored an exit as dialysis machine developer Outset Medical floated above its range in an upsized offering.

Astellas and Celgene-backed immuno-oncology therapy developer Oncorus has filed to raise up to $86.3m following more than $150m in funding.

The PayU and Rakuten-backed digital lending platform has filed for bankruptcy after regulatory changes in two markets meant customers halted loan repayments.

Small molecule drug developer C4 has fied for a $100m initial public offering, three months after the Dana-Farber Cancer Institute spinout raised a $170m round.

University of Stuttgart has scored an exit with the acquisition of nFrames, a 3D mapping technology spinout also backed by Vector Informatik.

The Sumitomo and Aflac-backed digital insurance and savings product provider has merged with Aviva Singapore to form a business valued above $2.3bn.

Kraft Group, Roche and Novartis are in line for exits after small molecule drug developer C4 filed for a $100m offering,

The MSU cancer drug spinout has been acquired on the strength of its expertise in proteasome inhibitors and preclinical pipeline.

Vector Venture Capital has exited nFrames, a developer of 3D surface reconstruction software that has been bought by Esri for an undisclosed amount.

Exosome therapy developer Codiak Biosciences – based on research at Gothenburg and MD Anderson Cancer Center – has filed to raise up to $100m.